Synergistic Anticancer Effects of Vorinostat and Epigallocatechin-3-Gallate against HuCC-T1 Human Cholangiocarcinoma Cells

The aim of this study was to investigate the effect of the combination of vorinostat and epigallocatechin-3-gallate against HuCC-T1 human cholangiocarcinoma cells. A novel chemotherapy strategy is required as cholangiocarcinomas rarely respond to conventional chemotherapeutic agents. Both vorinostat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwak, Tae Won, Kim, Do Hyung, Chung, Chung-Wook, Lee, Hye Myeong, Kim, Cy Hyun, Jeong, Young-IL, Kang, Dae Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706064/
https://www.ncbi.nlm.nih.gov/pubmed/23864881
http://dx.doi.org/10.1155/2013/185158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706064/
https://www.ncbi.nlm.nih.gov/pubmed/23864881
http://dx.doi.org/10.1155/2013/185158

Ejemplares similares